Tri-Coast Pharmacy Recalls Quad Mix Injection Due to Sterility Concerns
Tri-Coast Pharmacy is recalling Quad Mix compounded injections because the products may not be sterile. The recall covers vials compounded between May and November 2016.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of assurance of sterility in an injectable product, which poses a significant risk of serious injury or death if the product is contaminated.
Plain-English summary
Tri-Coast Pharmacy is recalling specific lots of Quad Mix, a compounded medication containing alprostadil, phentolamine, papaverine, and atropine. The recall is being issued because the products lack assurance of sterility. The affected products are 1 mL vials with a concentration of 10mcg/2mg/30mg/200mg/ml.
The recall includes all sterile products compounded between May 17, 2016, and November 17, 2016. One known lot code is 08102016F, which has an expiration date of September 18, 2016. The products were distributed nationwide.
Consumers and healthcare providers should stop using the affected products and contact their pharmacist or healthcare provider for further instructions. The recall is classified as Class II by the FDA.
The recalled product
- Product
- Quad Mix, Alprostadil/Phentolamine/Papaverine/Atropine 10mcg/2mg/30mg/200mg/ml, (1 ML). Compounded by Tri-Coast Pharmacy
- Manufacturer
- Tri-Coast Pharmacy
- Category
- Drug — Compounded Injectable
- Affected units
- 5
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 80 recalled by Tri-Coast Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 80 products in this recall →Related recalls
Same manufacturer · Tri-Coast Pharmacy
See all →- SevereTri-Coast Pharmacy Recalls TriMix Injection Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereTri-Coast Pharmacy Recalls Sermorelin Forte Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereTri-Coast Pharmacy Recalls TriMix Injection Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereTri-Coast Pharmacy Recalls BiMix Phentolamine/Papaverine Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereTri-Coast Pharmacy Recalls Quad Mix Sterile Compounded Drug
FDA (Drugs) · 2017-01-11
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29